FITX Creative Edge Nutrition Inc. (FITX) Launches the

New Post Public Reply Private Reply Replies (0) Message Board
Mariah The Wind
FITX

Creative Edge Nutrition Inc. (FITX) Launches the Cannabis Research Advisory Board With the Additions of Mike Colasanti and Dr...

MADISON HEIGHTS, MI / ACCESSWIRE / June 6, 2014 / Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX) is excited to announce the launch of the Cannabis Research Advisory Board focusing on diversifying technologies, techniques and platforms for the different ways of growing medicinal marijuana.

"We are proud to announce the addition of Mike Colasanti and Dr. Jim Sweetman, two great local men who have built their own legacy and bring decades of experience in their respective fields. They will play an integral role in the development of site two technologies allowing for the perfection of systems we can take to site one, once vetted by our medical quality board," states President & CEO Bill Chaaban.

With well over 35 years of grow experience, having touched so many lives in the heart of Windsor & Essex County, Mike Colasanti is excited about the new role he will have with Creative Edge Nutrition Inc. and CEN Biotech Inc. "Dr. Sweetman and I are very excited to take all of our life lessons and what we have learned and apply it to this very special project. This transition for the next chapter in Dr. Sweetman and I's lives will be a great one because it involves improving patients quality of life," stated Mike Colasanti.

BIO FOR MIKE COLASANTI

Mike Colasanti is the son of Joe and Barbara Colasanti, husband to Kelly Colasanti and partner of The Bloomin' Gardener. He brings with him over 35 years of growing experience.

At the age of 19, Mr. Mike Colansanti lived in Europe for a year working in the greenhouse business in Belgium, Holland, Germany, France and Italy. Blessed with the gift of an entrepreneurial spirit routing back to his Colasanti family business.

At a very young age Mr. Colasanti grew fondly of his passion to grow. Later on in his journey, Mr. Colasanti met his wife Kelly and launched The Bloomin Gardner, where together for 17 years of business practices has guided this dynamic duo to successful cultivation of many plants and gardens providing many homes with healthy nurtured plants in the heart of Windsor and Essex-County.

"My life has been a paved road in which I had to dodge the odd pot hole and then every so often a stretch of smooth road allows me to be at the right place with the right people. This time the road has lead me here; and I'm blessed to be a part of this pioneer project - growing medicinal cannabis for people that truly rely on it for its medicinal properties. I will strive for nothing less than growing the best medicine," stated Mike Colasanti.

BIO of Dr. JIM SWEETMAN

A grassroots Windsorite, Dr. Jim Sweetman exited high school in Windsor and went straight to the University of Guelph to study and receive his bachelors of Science in Agriculture with a focus in Microbiology.

Dr. Sweetman continued his journey by receiving a doctorate in Veterinary Medicine and furthermore Aqua Culture from the University of the Virgin Island.

As a Lakeshore resident and entrepreneur locally in downtown Windsor, Dr. Sweetman has his own veterinary practice and hospital.

His journey with Aqua Culture began in the early 1980's and has grown profoundly developing and utilizing many different Aquaponic technologies that he looks forward to utilizing on his exciting new journey with CEN Biotech Inc. and Creative Edge Nutrition.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Shareholder Investigations in Various Companies

Updated Category News Views 261

Overview of Current Shareholder Investigations Brodsky & Smith, a well-known litigation law firm, is actively reminding shareholders about various ongoing investigations involving Sealed Air Corporation, Movano Inc., Gulf Island Inc., and Denny's Corporation. If you are a shareholder interested in obtaining more information regarding these investigations, you can reach...

Continue Reading
Nykredit Announces Voluntary Tender Offer for Spar Nord Bank

Updated Category News Views 147

Nykredit Announces a Voluntary Public Tender Offer for Spar Nord Bank Nykredit Realkredit A/S, a prominent player in the Danish financial landscape, has publicly unveiled its plans for a voluntary tender offer directed at Spar Nord Bank A/S. This anticipated offer, which signals Nykredit's strategic expansion ambitions, seeks to acquire all available shares in Spar Nord...

Continue Reading
Big 5 Sporting Goods Embarks on New Growth Journey After Merger

Updated Category News Views 292

Big 5 Sporting Goods Corporation Announces Merger Completion Big 5 Sporting Goods Corporation (Nasdaq: BGFV), a well-established name in the sporting goods industry, has successfully completed its merger with a partnership composed of Worldwide Golf and Capitol Hill Group. This new chapter for Big 5 is expected to propel the company towards greater heights. Merger Details...

Continue Reading
UCB's BIMZELX® Data: A Game Changer for Arthritis Care

Updated Category News Views 132

UCB's Innovative Efforts in Arthritis Treatment UCB is making significant strides in the field of rheumatology, particularly with the release of new data regarding BIMZELX® (bimekizumab-bkzx) presented at the ACR Convergence 2024. This marks the first time the company has shared data specifically relating to psoriatic arthritis (PsA), non-radiographic axial...

Continue Reading
Mega Matrix Launches Captivating Urban Romance on FlexTV

Updated Category News Views 614

Engaging Romance Premieres on FlexTV Mega Matrix Inc. (NYSE American: MPU) has unveiled a captivating romantic miniseries titled A flash Marriage With The Billionaire Tycoon, streaming on its renowned short series platform, FlexTV. This adventurous drama dives into themes of love, responsibility, and the quest for personal redemption, showcasing the complicated lives of...

Continue Reading